Literature DB >> 19342598

Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.

Shu-Huei Wang1, Shing-Jong Lin, Yung-Hsiang Chen, Fen-Yen Lin, Jin-Chung Shih, Chau-Chung Wu, Hua-Lin Wu, Yuh-Lien Chen.   

Abstract

OBJECTIVE: The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury. METHODS AND
RESULTS: Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs-conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF.
CONCLUSIONS: We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342598     DOI: 10.1161/ATVBAHA.109.184739

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.

Authors:  Jorge Paz Rodriguez; Michael P Murphy; Soonjun Hong; Marialaura Madrigal; Keith L March; Boris Minev; Robert J Harman; Chien-Shing Chen; Ruben Berrocal Timmons; Annette M Marleau; Neil H Riordan
Journal:  Int Arch Med       Date:  2012-02-08

2.  PKH26 as a fluorescent label for live human umbilical mesenchymal stem cells.

Authors:  Zhu Shao-Fang; Zhang Hong-Tian; Zhong Zhi-Nian; He Yuan-Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-07-30       Impact factor: 2.416

Review 3.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

4.  Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.

Authors:  Wen-Ching Shen; Chan-Jung Liang; Vin-Cent Wu; Shu-Huei Wang; Guang-Huar Young; I-Rue Lai; Chung-Liang Chien; Seu-Mei Wang; Kwan-Dun Wu; Yuh-Lien Chen
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

5.  Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence.

Authors:  D Patschan; S Patschan; G A Müller
Journal:  Int J Nephrol       Date:  2011-04-27

6.  Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies.

Authors:  Min Gong; Yang Bi; Wei Jiang; Yun Zhang; Li Chen; Nali Hou; Youxue Liu; Xiaoping Wei; Jie Chen; Tingyu Li
Journal:  J Biomed Sci       Date:  2011-11-25       Impact factor: 8.410

Review 7.  Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization.

Authors:  Jung-Tung Liu; Yuh-Lien Chen; Wen-Chi Chen; Huey-Yi Chen; Yi-Wen Lin; Shu-Huei Wang; Kee-Ming Man; Hui-Min Wan; Wei-Hsian Yin; Po-Len Liu; Yung-Hsiang Chen
Journal:  J Biomed Biotechnol       Date:  2012-05-22

8.  Endothelium trans differentiated from Wharton's jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors.

Authors:  Valeria Aguilera; Luis Briceño; Hector Contreras; Liliana Lamperti; Esperanza Sepúlveda; Francisca Díaz-Perez; Marcelo León; Carlos Veas; Rafael Maura; Jorge Roberto Toledo; Paulina Fernández; Ambart Covarrubias; Felipe Andrés Zuñiga; Claudia Radojkovic; Carlos Escudero; Claudio Aguayo
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

Review 9.  Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Authors:  Thomas E Ichim; Timothy Warbington; Octav Cristea; Joseph L Chin; Amit N Patel
Journal:  J Transl Med       Date:  2013-06-09       Impact factor: 5.531

10.  Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.

Authors:  Maria Cristina Corotchi; Mirel Adrian Popa; Anca Remes; Livia Elena Sima; Ilinca Gussi; Marilena Lupu Plesu
Journal:  Stem Cell Res Ther       Date:  2013-07-11       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.